NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager
NTRK CONNECT identified NTRK Gene Fusions on the ESMO OncologyPro portal as a practical guide on how to test for NTRK gene fusions and treat with TRK inhibitors.
Prof. Andrea Sartore-Bianchi
Medical Oncologist
Niguarda Cancer Center
Italy
Prof. Fernando López-Ríos
Pathologist
12 de Octubre University Hospital, Madrid
Spain
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
| 
5 min
|
2019
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
NTRK CONNECT have now developed BluePrint documents as a reference guide providing a concise overview in downloadable formats. A variety of topics are covered including, overview of gene fusions and role as oncogenic drivers, detection approaches available, NTRK family and NTRK gene fusions, epidemiology of cancers with NTRK gene fusions and an overview of TRK inhibitors.
PRECISION ONCOLOGY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca and Bayer.
Other programmes of interest
2 min
Other programmes developed by Prof. Andrea Sartore-Bianchi
Prof. Andrea Sartore-Bianchi
Medical Oncologist
Niguarda Cancer Center
Italy
Other programmes developed by Prof. Fernando López-Ríos
Prof. Fernando López-Ríos
Pathologist
12 de Octubre University Hospital, Madrid
Spain
Other programmes developed by Assoc. Prof. Gerald Prager
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
